Regeneron and Diebold Lead Major Stock Price Percentage Winners Today
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Leerink raised its target range for Regeneron shares after the company raised its 2012 revenue guidance substantially. The firm keeps an Outperform rating on the stock. The shares closed at $114.65, up $12.57, or 12.31%. They have traded in a 52-week range of $34.77 to $105.42.
Diebold Incorporated (NYSE:DBD): On February 8 the Board of Directors of the company authorized the Company to repurchase up to an additional 2M of its common shares. This authorization is in addition to the approximately 0.4M shares that the Company may repurchase pursuant to its existing board authorization. The timing of repurchases will depend upon several factors, including market and business conditions, and the repurchases may be discontinued at any time.. The shares closed at $37.94, up $3.19, or 9.18%. They have traded in a 52-week range of $24.70 to $37.12.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org